Evidence map›Paper›PMID 34835003›Full record

ReviewViruses2021

Regulation of Viral Restriction by Post-Translational Modifications.

Célia Chamontin, Guillaume Bossis, Sébastien Nisole, Nathalie J Arhel, Ghizlane Maarifi

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Regulatory mimicry of cyclin-dependent kinases by a conserved herpesvirus protein kinase.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Metformin Enhances Antibody-Mediated Recognition of HIV-Infected CD4bioRxiv : the preprint server for biology · 2024
    Article
  13. Review
  14. Article
  15. The helicase-like transcription factor redirects the autophagic flux and restricts human T cell leukemia virus type 1 infection.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Célia ChamontinViral Trafficking, Restriction and Innate Signaling Team, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, CNRS, CEDEX 5, 34293 Montpellier, France.
Guillaume BossisThe Ubiquitin Family in Hematologic Malignancies Team, Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier, CNRS, CEDEX 5, 34293 Montpellier, France.ORCID 0000-0002-3349-8250
Sébastien NisoleViral Trafficking, Restriction and Innate Signaling Team, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, CNRS, CEDEX 5, 34293 Montpellier, France.ORCID 0000-0001-9793-419X
Nathalie J ArhelViral Trafficking, Restriction and Innate Signaling Team, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, CNRS, CEDEX 5, 34293 Montpellier, France.ORCID 0000-0001-5309-1725
Ghizlane MaarifiViral Trafficking, Restriction and Innate Signaling Team, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, CNRS, CEDEX 5, 34293 Montpellier, France.ORCID 0000-0002-7974-3821
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intrinsic immunity is orchestrated by a wide range of host cellular proteins called restriction factors. They have the capacity to interfere with viral replication, and most of them are tightly regulated by interferons (IFNs). In addition, their regulation through post-translational modifications (PTMs) constitutes a major mechanism to shape their action positively or negatively. Following viral infection, restriction factor modification can be decisive. Palmitoylation of IFITM3, SUMOylation of MxA, SAMHD1 and TRIM5α or glycosylation of BST2 are some of those PTMs required for their antiviral activity. Nonetheless, for their benefit and by manipulating the PTMs machinery, viruses have evolved sophisticated mechanisms to counteract restriction factors. Indeed, many viral proteins evade restriction activity by inducing their ubiquitination and subsequent degradation. Studies on PTMs and their substrates are essential for the understanding of the antiviral defense mechanisms and provide a global vision of all possible regulations of the immune response at a given time and under specific infection conditions. Our aim was to provide an overview of current knowledge regarding the role of PTMs on restriction factors with an emphasis on their impact on viral replication.

Indexed as

Host-Pathogen InteractionsProtein Processing, Post-TranslationalVirus DiseasesAntigens, CDAntiviral Restriction FactorsBone Marrow Stromal Antigen 2GlycosylationGPI-Linked ProteinsHumansMembrane ProteinsMyxovirus Resistance ProteinsRNA-Binding ProteinsSAM Domain and HD Domain-Containing Protein 1SumoylationTripartite Motif ProteinsUbiquitinationAntigens, CDAntiviral Restriction FactorsBone Marrow Stromal Antigen 2BST2 protein, humanGPI-Linked ProteinsIFITM3 protein, humanMembrane ProteinsMX1 protein, humanMyxovirus Resistance ProteinsRNA-Binding ProteinsSAM Domain and HD Domain-Containing Protein 1SAMHD1 protein, humanTRIM5 protein, humanTripartite Motif ProteinsUbiquitin-Protein LigasesViral Proteinsdegradationintrinsic immunitypost-translational modificationsrestriction factors

Identifiers

PMID34835003
PMCPMC8618861
OpenAlexW3208081251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.